[{"Assets_0_Q1_USD":231627000.0,"CommonStockSharesOutstanding_0_Q1_shares":7026717.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-12100000.0,"NetIncomeLoss_1_Q1_USD":-8268000.0,"StockholdersEquity_0_Q1_USD":-119178000.0,"Ticker":"NGM","CIK":"1426332","name":"NGM BIOPHARMACEUTICALS INC","OfficialName":"NGM Biopharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1227500649.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190516"}]